Get the Stockscreener App
2.47
10.51%
-0.29
22nd Century Group, Inc. stock is traded at $2.47, with a volume of 295.76K.
It is down -10.51% in the last 24 hours and down -66.85% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$2.76
Open:
$2.65
24h Volume:
295.76K
Relative Volume:
0.29
Market Cap:
$1.24M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.0399
EPS:
-61.9139
Net Cash Flow:
$-16.12M
1W Performance:
-19.54%
1M Performance:
-66.85%
6M Performance:
-39.90%
1Y Performance:
-97.33%
1-Day Range:
$2.4401
$2.67
1-Week Range:
$2.4401
$3.93
52-Week Range:
$0.432
$101.25
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
2.47 | 948.82K | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
Why is 22nd Century Group Inc. stock attracting strong analyst attentionEntry Signal Watchlist With High Returns - jammulinksnews.com
How many analysts rate 22nd Century Group Inc. as a “Buy”Smart Portfolio Recommendation For Beginners - jammulinksnews.com
What is 22nd Century Group Inc. company’s growth strategySwing Trade Target Finder With Low Risk - jammulinksnews.com
What institutional investors are buying 22nd Century Group Inc. stockReal Time Tracker For Fast Growth - jammulinksnews.com
What are analysts’ price targets for 22nd Century Group Inc. in the next 12 monthsChart Pattern Trend Scanner With Low Risk - jammulinksnews.com
What is the risk reward ratio of investing in 22nd Century Group Inc. stockValue Investing Guidance To Watch Now - jammulinksnews.com
How strong is 22nd Century Group Inc. company’s balance sheetBest Dividend Ideas For Beginners - jammulinksnews.com
What are the latest earnings results for 22nd Century Group Inc.Earnings Report Tips Backed By Experts - jammulinksnews.com
Will 22nd Century Group Inc. stock recover after recent dropROI Boosting Trade Opportunity Calendar Published - metal.it
22nd Century Group, Inc. Highlights FDA Authorization of VLN® Products as Compliant Reduced Nicotine Cigarettes - Quiver Quantitative
22nd Century Applauds the American Academy of Family Physicians Comments and Support of the FDA’s Proposed Reduced Nicotine Mandate to Reduce Smoking, Transform Public Health, Save Lives and Reduce Health Costs - The Manila Times
22nd Century Group comments on FDA’s proposed nicotine standard - Investing.com
Medical Group Backs FDA's Historic Nicotine Ban: 22nd Century Holds Exclusive Compliant Products - Stock Titan
What makes 22nd Century Group Inc. stock attractive to long term investorsHigh Yield Stock Screening Results Explained - metal.it
XXII Stock Surge: Time for Action? - StocksToTrade
22nd Century Group Inc. Breaks Losing Streak — Is the Trend ReversingConfirmed Setup With Expert Accuracy Supported - metal.it
22nd Century Group: Resurgence and Future Prospects - StocksToTrade
22nd Century Group’s Bold Leap: A Market Game-Changer? - timothysykes.com
Should I hold or sell 22nd Century Group Inc. stock in 2025Build a diversified portfolio for stability - jammulinksnews.com
What catalysts could drive 22nd Century Group Inc. stock higher in 2025Get exclusive market insights for better trading - jammulinksnews.com
Is 22nd Century Group Inc. a growth stock or a value stockFree Trading Strategy Suggestions - jammulinksnews.com
22nd Century Group Inc. Stock Performance After Earnings: Historical InsightsFree AI-Powered Stock Predictions - beatles.ru
Will 22nd Century Group Inc. Stock Benefit from AI and Green Energy TrendsFree Real-Time Stock Data - metal.it
Why 22nd Century Group Inc. stock attracts strong analyst attentionFree Stock Market Insider Analysis - metal.it
How 22nd Century Group Inc. stock performs during market volatilityTrade Ready Signal - metal.it
Should I buy 22nd Century Group Inc. stock before earningsUnprecedented profits - jammulinksnews.com
VLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine Mandate - ADVFN Brasil
What drives 22nd Century Group Inc. stock priceSkyrocketing investment returns - PrintWeekIndia
Is 22nd Century Group Inc. a good long term investmentAccelerated financial growth - Autocar Professional
What analysts say about 22nd Century Group Inc. stockExplosive wealth accumulation - jammulinksnews.com
22nd Century Group Inc. Stock Analysis and ForecastTremendous financial leverage - Autocar Professional
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):